Pharmacology related to paediatric anaesthesia

Meghna Maheshwari1, Sadhana Sanwatsarkar1, Milind Katakwar1

  • 1Department of Anaesthesiology and Critical Care, Sri Aurobindo Medical College and PG Institute, Indore, Madhya Pradesh, India.

Insights

Children metabolize drugs differently than adults due to immature organ systems. Understanding paediatric pharmacokinetics and pharmacodynamics is crucial for safe and effective drug therapy in children.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Drug Metabolism

Background:

  • Children are not small adults; their physiological and psychological development significantly impacts drug response.
  • Immature organ systems in pediatric patients necessitate specialized knowledge of drug handling.
  • Differences in pharmacokinetics and pharmacodynamics between children and adults can lead to underdosing or toxicity.

Purpose of the Study:

  • To simplify and review the fundamental principles of pharmacokinetics and pharmacodynamics in the pediatric population.
  • To highlight the key physiological and pharmacological distinctions between pediatric and adult patients.
  • To provide essential knowledge for safe and effective drug administration in children.

Main Methods:

  • Comprehensive literature search of PubMed using keywords: pharmacology, child, pediatric anesthesia.
  • Hand-searched references from relevant review articles and textbook chapters.
  • Focused on drug interactions, neuromuscular junction pharmacology, and anesthetic effects on the developing brain.

Main Results:

  • Pediatric patients exhibit unique pharmacokinetic and pharmacodynamic profiles compared to adults.
  • Drug disposition and effects are significantly influenced by growth and developmental stages.
  • Understanding these differences is vital for optimizing pediatric drug therapy and avoiding adverse events.

Conclusions:

  • A foundational understanding of pediatric pharmacokinetics and pharmacodynamics is essential for healthcare professionals.
  • Tailoring drug regimens based on age-specific physiological parameters improves treatment outcomes.
  • Further research into pediatric drug metabolism and effects is warranted to enhance patient safety.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
226